Electromagnetic (EM) hyperthermic technologies hold great potential in the treatment of diseases, especially for cancers that are resistant to standard regimens. These technologies modify tissue temperature: hyperthermia heats the diseased tissue to make it susceptible to treatments, and ablation heats the tissue until it is destroyed. Hyperthermia is particularly effective in treatment of cervical and breast cancer, head and neck cancers, sarcoma in adults, and germ cell tumours in children; while radiofrequency and microwave ablation offer promise for treating liver, kidney, and lung cancers.

Latest News



Our Action will be participating in the next International Congress of Hyperthermia Oncology held between 6th and 9th October, 2021…

Read more

Working group 2 Online Meeting

Following the success of our last virtual meeting, we will be following it up with another meeting on the 9th…

Read more

[OPEN] Call: 2019/2020 Key publications

Dear MyWAVE members, We are pleased to announce the upcoming MyWAVE Top 10 publications related to the topics of MyWAVE,…

Read more

Working Groups

Working Group 1

This group will focus on fundamental dielectric and thermal research of biological tissues, with two main Focus Areas (FAs): creating…

Working Group 2

This group works on three focus areas: optimising the technology for existing thermal-based EM applications and developing ideas for novel…

Working Group 3

This group supports the commercial translation of EM therapeutic technologies through two focus areas: provide and support training on clinical…